About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...

Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

Many people are wearing glucose monitors despite them not having diabetes as an approach to weight loss and to improve ...

A collaborative effort across 14 clinical centers in Canada and Australia reports that pregnant women with type 1 diabetes ...

Professor Mirella Di Lorenzo’s research is focused on harnessing power from natural and underutilised sources, including soil and wastewater. As well as a Professor in Bath’s Department of Chemical ...

DexCom (DXCM) stock ought to be included on your watchlist. Here is why – it is presently trading within the support range ...

Continuous glucose monitoring can identify unrecognized hyperglycemia and hypoglycemia in dialysis patients, challenging reliance on A1c for diabetes management.

November is National Diabetes Awareness Month, highlighting a condition that affects 830 million people worldwide, including over 38 million Americans.Diabetes ...

Dexcom Inc. executives may have thought a $30 million beat of the consensus estimates for third quarter revenue and 20% growth year-over-year provided a treat to shareholders, but investors seemed to ...

After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...

Amid some scrutiny over its latest-generation G7 CGM, Dexcom officials addressed claims on the company's latest earnings call ...

By Sneha S K (Reuters) -Dexcom shares tumbled 12.8% on Friday after executives signaled that the medical device maker's 2026 ...